Elastrin Therapeutics
Latest round
- Seed
Last raised
- Apr 2022
Total raised
- $3.6M
Investors
- 3
About Elastrin Therapeutics
Based in the US, Elastrin Therapeutics Inc.Elastrin Therapeutics Inc. specializes in creating biopharmaceutical products targeting cardiovascular health, aiming for significant advancements in patient care. Founded in 2017, the company has not undergone any major pivots in business strategy. The firm is headquartered in the US. The co-founders include Douglas Mulhall and Naren Vyavahare, while Matthias Breugelmans serves as the CEO.Elastrin Therapeutics Inc. develops therapies aimed at addressing the root causes of cardiovascular diseases. Their main products are advanced biopharmaceuticals designed to enhance vascular health and restore elasticity in cardiovascular tissues. These therapies are crucial for preventing and treating various heart conditions, including hypertension, heart failure, and atherosclerosis.Elastrin Therapeutics operates through a transaction model driven by partnerships with healthcare institutions and direct sales to medical facilities. Their revenue generation strategy is facilitated by subscription agreements for ongoing access to their therapies, alongside collaborations with pharmaceutical companies for development and distribution.In April 2022, Elastrin Therapeutics Inc. The funds will be utilized to expand operations and boost development efforts. The company is focusing on launching new products aimed at improving cardiovascular treatment options, while also targeting expansion into North American and European markets by the end of 2023.
Who invested in Elastrin Therapeutics
3 investors across 2 rounds
See all investors in Elastrin Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elastrin Therapeutics
Who invested in Elastrin Therapeutics?
Elastrin Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elastrin Therapeutics raised?
Elastrin Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Elastrin Therapeutics last raise money?
Elastrin Therapeutics's most recent round on record is a Seed, in Apr 2022.
What does Elastrin Therapeutics do?
Based in the US, Elastrin Therapeutics Inc.
Where is Elastrin Therapeutics headquartered?
Elastrin Therapeutics is headquartered in US.
Which VCs invest in companies like Elastrin Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elastrin Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Elastrin Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.